Effects of intra-accumbens injection of 2-methylthio ATP: A combined open field and electroencephalographic study in rats

Psychopharmacology

Volumn 150, Issue 2, 2000, Pages 123-131

  Kittner, Holger ^a   Krügel, Ute ^a   Hoffmann, Eike ^a   Illes, Peter ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

2 Methylthio ATP; Dopamine D1 receptor; Dopamine D2 receptor; EEG power spectrum; Locomotor activity; Nucleus accumbens; P2 receptor

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CIBACRON BLUE F3GA; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; OXIDOPAMINE; PURINE P2 RECEPTOR; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; SULPIRIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG MECHANISM; ELECTROENCEPHALOGRAPHY; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ADENOSINE TRIPHOSPHATE; ADRENERGIC AGENTS; ANIMALS; DOPAMINE ANTAGONISTS; ELECTROENCEPHALOGRAPHY; MALE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; OXIDOPAMINE; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P2; THIONUCLEOTIDES;

EID: 0033948002     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130000403     Document Type: Article

References (52)

1. Abbracchio MP, Burnstock G (1994) Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64:445-475
2. Amalric M, Ouagazzal A, Baunez C, Nieoullon A (1994) Functional interactions between glutamate and dopamine in the rat striatum. Neurochem Int 25:123-131
3. 2A receptors in the nucleus accumbens. Prog Neuropsychopharmacol Biol Psychiatry 18:545-553
4. Brudzynski SM, Mogenson GJ (1985) Association of the mesencephalic locomotor activity induced by injections of amphetamine into the nucleus accumbens. Brain Res 334:77-84
5. 2-purinoceptor antagonists discriminate three contraction-mediating receptors for ATP in rat vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 349:74-80
6. Burnstock G (1986) The changing face of autonomic neurotransmission. Acta Physiol Scand 126:67-91
7. Carlezon WA, Wise RA (1996) Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J Neurosci 16:3112-3122
8. Clarke PB, Jakubovic A, Fibiger HC (1988) Anatomical analysis of the involvement of mesolimbocortical dopamine in the locomotor stimulant actions of d-amphetamine and apomorphine. Psychopharmacology 96:511-520
9. Colle LM, Wise RA (1991) Circling induced by intra-accumbens aphetamine injections. Psychopharmacology 105:157-161
10. Costall B, Naylor RJ (1975) The behavioral effects of dopamine applied intracerebrally to the areas of the mesolimbic system. Eur J Pharmacol 32:87-92
11. Cummings JL (1995) Anatomical and behavioural aspects of frontal subcortical circuits. Ann NY Acad Sci 769:1-13
12. Dale N, Gilday D (1996) Regulation of rhythmic movements by purinergic neurotransmitters in frog embryos. Nature 383: 259-263
13. 2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats. Brain Res 487:267-277
14. Feenstra MG, Botterblom MH, van Uum JF (1995) Novelty-induced increase in dopamine release in the rat prefrontal cortex in vivo; inhibition by diazepam. Neurosci Lett 189:81-94
15. Ferré S, Fuxe K, von Euler G, Johansson B, Fredholm BB (1992) Adenosine-dopamine interactions in the brain. Neuroscience 51:501-512
16. 2 receptors. Psychopharmacology 114:297-308
17. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M (1994) Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143-156
18. 2 purinoceptor types in rat locus coeruleus neurons. Eur J Pharmacol 315:255-261
19. Humphrey PP, Buell G, Kennedy I, Khakh BS, Michel AD, Suprenant A, Trezise DJ (1995) New insights on P2x purinoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 352:585-596
20. Illes P, Nörenberg W (1993) Neuronal ATP receptors and their mechanism of action. Trends Pharmacol Sci 14:50-54
21. Illes P, Nieber K, Nörenberg W (1996) Electrophysiological effects on brain neurones. J Auton Pharmacol 16:407-411
22. Imperato A, Tanda G, Frau R, Di Chiara G (1988) Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rat. J Pharmacol Exp Ther 245:257-264
23. Inoue K, Koizumi S, Ueno S (1996) Implications of ATP receptors in brain functions. Prog Neurobiol 50:483-492
24. Kelly PH, Seviour PW, Iversen SD (1975) Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94:507-522
25. 2-purinoceptor subtypes - an update. Arch Int Pharmacodyn Ther 303:30-50
26. Kennedy C, Leff P (1995) How should P2X purinoceptors be classified pharmacologically? Trends Pharmacol Sci 16:168-174
27. Khakh BS, Henderson G (1998) ATP receptor-mediated enhancement of fast excitatory neurotransmitter release in the brain. Mol Pharmacol 54:372-378
28. Kropf W, Kuschinsky K (1991) Electroencephalographic correlates of the sedative effects of dopamine agonist presumably acting on autoreceptors. Neuropharmacology 30:953-960
29. Kropf W, Kriegelstein J, Kuschinsky K (1992) Effects of stimulation of putative dopamine autoreceptors on electroencephalographic power spectrum in comparison with effects produced by blockade of postsynaptic dopamine receptors in rats. Eur Neuropsychopharmacol 2:467-474
30. Krügel U, Kittner H, Illes P (1999) Adenosine 5'-triphosphate-induced dopamine release in the rat nucleus accumbens in vivo. Neurosci Lett 265:49-52
31. Kuczenski R (1983) Biochemical actions of amphetamine and other stimulants. In: Creese I (ed) Stimulants: neurochemical, behavioral and clinical perspectives. Raven Press, New York, pp 31-61
32. Machleidt W, Gutjahr L, Hinrichs H (1994) Die EEG Spektralmuster der Grundgefühle: Hunger, Angst, Aggression, Trauer und Freude. EEG-EMG 25:81-97
33. McKenzie JS, Shafton AD, Stewart CA (1991) Intrastriatal dopaminergic agents, muscarinic stimulation, and GABA antagonism compared for rotation responses in rats. Behav Brain Res 45:163-170
34. Meredith GE, Pennartz CM, Groenewegen HJ (1993) The cellular framework for chemical signalling in the nucleus accumbens. Prog Brain Res 99:3-24
35. Meyer ME (1993) Effects of intraaccumbens dopamine agonist SK&F38393 and antagonist SCH23390 on locomotor activities in rats. Pharmacol Biochem Behav 45:843-847
36. Mogenson GJ, Jones DL, Yim CY (1980) from motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol 14:69-97
37. Nakazawa K, Inoue K, Ito K, Koizumi S, Inoue K (1995) Inhibition by suramin and reactive blue 2 of GABA and glutamate receptor channels in rat hippocampal neurons. Naunyn-Schmiedeberg's Arch Pharmacol 351:202-208
38. Neisewander JL, O'Dell LE, Redmond JC (1995) Localization of dopamine receptor subtypes occupied by intra-accumbens antagonists that reverse cocaine-induced locomotion. Brain Res 671:201-212
39. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press, San Diego
40. Pijnenburg AJJ, van Rossum JM (1973) Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens. J Pharm Pharmacol 25:1003-1005
41. Pulvirenti L, Berrier R, Kreifeldt M., Koob GF (1994) Modulation of locomotor activity by NMDA receptors in the nucleus accumbens core and shell regions of the rat. Brain Res 664:231-236
42. Schildein S, Agmo A, Huston JP, Schwarting RKW (1998) Intraaccumbens injections of substance P, morphine and amphetamine: effects on conditioned place preference and behavioral activity. Brain Res 790:185-194
43. 2-like dopamine receptors. Psychopharmacology 133:77-84
44. Ungerstedt U (1971) Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand Suppl 367:1-48
45. von Kügelgen I, Starke K (1991) Noradrenaline-ATP co-transmission in the sympathetic nervous system. Trends Pharmacol Sci 12:319-324
46. White TD (1988) Role of adenine compounds in autonomic neurotransmission. Pharmacol Ther 38:129-168
47. Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492
48. Yang CR, Mogenson GJ (1985) An electrophysiological study of the neural projections from the hippocampus to the ventral pallidum and the subpallidal areas by way of the nucleus accumbens. Neuroscience 15:1015-1024
49. Zetterstrom T, Fillenz M (1990) Adenosine agonists can both inhibit and enhance in vivo striatal dopamine release. Eur J Pharmacol 180:137-143
50. Zhang Y-X, Yamashita H, Ohshita T, Sawamoto N, Nakamura S (1995) ATP increases extracellular dopamine level through stimulation of P2Y purinoceptors in the rat striatum. Brain Res 691:205-212
51. Zimmermann H (1994) Signalling via ATP in the nervous system. Trends Neurosci 17:420-426
52. Zimmermann H (1996) Extracellular purine metabolism. Drug Dev Res 39:168-174